Tiziana Life Sciences Insider Trades
NASDAQ: TLSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $1.04M
- Sales
- 0 · $0
- Shares bought / sold
- 1.05M / 0
- Net activity
- Net buying $1.0 million
Tiziana Life Sciences insider activity
Over the last 12 months, Tiziana Life Sciences insiders reported 8 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $1.0 million and sold $0 worth of stock, for net insider buying of $1.0 million. The most recent filing shows Elrifi Ivor (Chief Executive Officer) reporting a transaction in 1,050,000 shares on Aug 15, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TLSA's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TLSA insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 15, 2026 | Elrifi IvorChief Executive Officer | Option exercise | 1,050,000 | — | Form 4 |
| Aug 5, 2026 | Elrifi IvorChief Executive Officer | Buy | 237,616 | $237.62K | Form 4 |
| Aug 4, 2026 | Elrifi IvorChief Executive Officer | Buy | 83,807 | $81.29K | Form 4 |
| Aug 3, 2026 | Elrifi IvorChief Executive Officer | Buy | 667,000 | $667.00K | Form 4 |
| Jul 21, 2026 | CERRONE GABRIELE MDirector | Award | 42,357 | $41.93K | Form 4 |
| Jul 21, 2026 | CERRONE GABRIELE MDirector | Buy | 42,357 | $41.93K | Form 4 |
| Jun 12, 2026 | CERRONE GABRIELE MDirector | Award | 15,000 | $16.65K | Form 4 |
| Jun 12, 2026 | CERRONE GABRIELE MDirector | Buy | 15,000 | $16.65K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4